THE HEALTH IMPACT PROJECTION MODEL OF THE PD-1/PD-L1 INHIBITOR CLASS IN CANCER CARE IN TURKEY

dc.contributor.authorAkpamuk, U.
dc.contributor.authorHughes, R.
dc.contributor.authorSwales, O.
dc.contributor.authorOyan, B.
dc.contributor.authorKilickap, S.
dc.contributor.authorDemirci, U.
dc.contributor.authorSendur, M. A.
dc.contributor.authorSonmez, O.
dc.contributor.authorYazici, O.
dc.contributor.authorMalhan, S.
dc.contributor.authorOksuz, E.
dc.contributor.authorTuzer, E.
dc.contributor.authorErsoy, Akyol B.
dc.contributor.authorPoellinger, B.
dc.date.accessioned2025-10-16T15:17:09Z
dc.date.issued2022
dc.identifier.otherWOS:000828757300381
dc.identifier.urihttps://openaccess.acibadem.edu.tr/handle/11443/6869
dc.publisherELSEVIER SCIENCE INC
dc.sourceVALUE IN HEALTH
dc.titleTHE HEALTH IMPACT PROJECTION MODEL OF THE PD-1/PD-L1 INHIBITOR CLASS IN CANCER CARE IN TURKEY
dc.typeMeeting Abstract

Dosyalar

Koleksiyonlar